SCHEMBL17523369

SCHEMBL17523369

Cc1cc(N2CC[C@H](O)C2)nc2cc([C@@H]3CCCCN3C(=O)c3cc(Cl)ccc3NS(C)(=O)=O)nn12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2737927 1.00 — —
SCHEMBL2737924 0.96 — —
SCHEMBL2737487 0.93 CCKBR (0.34) —
SCHEMBL15316942 0.93 CCKBR (0.34) —
SCHEMBL2737484 0.93 MCHR1 (0.36) —
SCHEMBL15317087 0.92 DPP4 (0.37) —
SCHEMBL2737486 0.92 MCHR1 (0.36) —
SCHEMBL15317097 0.92 HRH4 (0.37) —
SCHEMBL2737492 0.91 CCKBR (0.35) —
SCHEMBL2737481 0.91 CCKBR (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160045528-A1 COMBINATION THERAPY FOR TREATING A PARAMYXOVIRUS ALIOS BIOPHARMA, INC. 2016-02-18 — — US disclosed
Send feedback